Link Begins First Human Test of Dual Antigen CAR T
Link Cell Therapies initiated clinical dosing of LNK001, an autologous logic-gated CAR-T therapy that requires coexpression of CAIX and ENPP3, in a Phase 1 clear-cell renal-cell-carcinoma study at MD Anderson. The design directly addresses…
